Effect of Temporary Spinal Cord Stimulation on Postherpetic Neuralgia in the Thoracic Nerve Area

Moriyama, Kazuhide

doi:10.1111/j.1525-1403.2009.00186.x

Cited by 30 publications

(30 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, SCS has also been proposed as a short-term therapy for subacute herpes zoster or beginning postherpetic neuralgia. Here, a 14-day short-term therapy with an externalized electrode led to complete and lasting pain relief in some patients 94,95…”

Section: Indicationsmentioning

confidence: 99%

Spinal cord stimulation for neuropathic pain: current perspectives

Wolter¹

2014

JPR

View full text Add to dashboard Cite

Neuropathic pain constitutes a significant portion of chronic pain. Patients with neuropathic pain are usually more heavily burdened than patients with nociceptive pain. They suffer more often from insomnia, anxiety, and depression. Moreover, analgesic medication often has an insufficient effect on neuropathic pain. Spinal cord stimulation constitutes a therapy alternative that, to date, remains underused. In the last 10 to 15 years, it has undergone constant technical advancement. This review gives an overview of the present practice of spinal cord stimulation for chronic neuropathic pain and current developments such as high-frequency stimulation and peripheral nerve field stimulation.

show abstract

Section: Indicationsmentioning

confidence: 99%

Spinal cord stimulation for neuropathic pain: current perspectives

Wolter¹

2014

JPR

View full text Add to dashboard Cite

show abstract

“…Neurosurgery may trigger HZ [269–271] and though neuroablation has also been used, its efficacy is unproven and it may exacerbate PHN [757]; neuromodulation may provide an alternative but needs further investigation [758, 759]. …”

Section: Management and Preventionmentioning

confidence: 99%

Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

et al. 2017

View full text Add to dashboard Cite

BackgroundHerpes zoster (HZ) is a prevalent viral disease that inflicts substantial morbidity and associated healthcare and socioeconomic burdens. Current treatments are not fully effective, especially among the most vulnerable patients. Although widely recommended, vaccination against HZ is not routine; barriers in Asia-Pacific include long-standing neglect of adult immunisation and sparse local data. To address knowledge gaps, raise awareness, and disseminate best practice, we reviewed recent data and guidelines on HZ from the Asia-Pacific region.MethodsWe searched PubMed, Scopus, and World Health Organization databases for articles about HZ published from 1994 to 2014 by authors from Australia, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, New Zealand, the Philippines, Singapore, Taiwan, Thailand, and Vietnam. We selected articles about epidemiology, burden, complications, comorbidities, management, prevention, and recommendations/guidelines. Internet searches retrieved additional HZ immunisation guidelines.ResultsFrom 4007 retrieved articles, we screened-out 1501 duplicates and excluded 1264 extraneous articles, leaving 1242 unique articles. We found guidelines on adult immunisation from Australia, India, Indonesia, Malaysia, New Zealand, the Philippines, South Korea, and Thailand.HZ epidemiology in Asia-Pacific is similar to elsewhere; incidence rises with age and peaks at around 70 years – lifetime risk is approximately one-third. Average incidence of 3–10/1000 person-years is rising at around 5% per year. The principal risk factors are immunosenescence and immunosuppression. HZ almost always causes pain, and post-herpetic neuralgia is its most common complication. Half or more of hospitalised HZ patients have post-herpetic neuralgia, secondary infections, or inflammatory sequelae that are occasionally fatal. These disease burdens severely diminish patients’ quality of life and incur heavy healthcare utilisation.ConclusionsSeveral countries have abundant data on HZ, but others, especially in South-East Asia, very few. However, Asia-Pacific countries generally lack data on HZ vaccine safety, efficacy and cost-effectiveness. Physicians treating HZ and its complications in Asia-Pacific face familiar challenges but, with a vast aged population, Asia bears a unique and growing burden of disease. Given the strong rationale for prevention, most adult immunisation guidelines include HZ vaccine, yet it remains underused. We urge all stakeholders to give higher priority to adult immunisation in general and HZ in particular.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-017-2198-y) contains supplementary material, which is available to authorized users.

show abstract

“…However, in another study, no change between the pre- and postprocedural analgesic medication dose was reported in the 21 patients who observed analgesic effects of the SCS [14]. No major complications were reported other than transient hypotension (3/14 patients), urinary retention (7/14 patients) and a snapped quadripolar lead where the procedure had to be repeated [14, 17]. …”

Section: Resultsmentioning

confidence: 99%

“…In 3 studies with available data, all patients were unsuccessfully treated with antiviral agents, epidural and/or nerve blocks and multiple pain medications including gabapentin, pregabalin, nonsteroidal anti-inflammatory drugs, opioids, antiepileptics and antidepressants [14, 16, 17]. The SCS was performed at the thoracic (81.7%), cervical (12.3%), lumbar (2%) and cervicomedullary junction (4%) levels after a mean of 17.6 months following zoster onset.…”

Section: Resultsmentioning

confidence: 99%

Neurosurgeons’ Armamentarium for the Management of Refractory Postherpetic Neuralgia: A Systematic Literature Review

Texakalidis

Tora

Boulis

2019

Stereotact Funct Neurosurg

View full text Add to dashboard Cite

Background/Aims: Postherpetic neuralgia (PHN) can be refractory to both medical and minimally invasive treatments. Its complex pathophysiology explains the numerous neurosurgical procedures that have been implemented through the years. Our objective was to summarize all available neurosurgical strategies for the management of resistant PHN and evaluate their respective safety and efficacy outcomes. Methods: A comprehensive systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 38 studies comprising 811 patients with refractory PHN were included. The safety and efficacy of the following procedures were investigated: spinal cord stimulation (SCS), dorsal root entry zone (DREZ) lesioning, intrathecal drug delivery, caudalis DREZ lesioning, dorsal root ganglion (DRG) radiofrequency lesioning, peripheral nerve stimulation, gamma knife surgery, deep brain stimulation, cordotomy, percutaneous radiofrequency rhizotomy and Gasserian ganglion stimulation. Conclusions: There are several available neurosurgical approaches for recalcitrant PHN including neuromodulatory and ablative procedures. It is suggested that patients with resistant PHN undergo minimally invasive procedures first, including SCS, peripheral nerve stimulation or DRG radiofrequency lesioning. More invasive procedures should be reserved for refractory cases. Comparative studies are needed in order to construct a PHN neurosurgical management algorithm.

show abstract

Effect of Temporary Spinal Cord Stimulation on Postherpetic Neuralgia in the Thoracic Nerve Area

Cited by 30 publications

References 5 publications

Spinal cord stimulation for neuropathic pain: current perspectives

Spinal cord stimulation for neuropathic pain: current perspectives

Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

Neurosurgeons’ Armamentarium for the Management of Refractory Postherpetic Neuralgia: A Systematic Literature Review

Contact Info

Product

Resources

About